v3.26.1
Consolidated Statements of Equity (Deficit) - USD ($)
$ in Thousands
Total
Series A Preferred Stock
Series B Preferred Stock
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Series A Preferred Stock
Accumulated Deficit
Series B Preferred Stock
Accumulated Other Comprehensive (Loss) Income
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2023       4,563 29,937,067            
Beginning balance at Dec. 31, 2023 $ 359,566     $ 0 $ 3 $ 572,170 $ (281,285)     $ 229 $ 68,449
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
ESPP shares issued and vesting of restricted stock, net of shares withheld for employer taxes (in shares)         325,961            
ESPP shares issued and vesting of restricted stock, net of shares withheld for employer taxes (3,218)         (3,218)          
Common stock issued upon exercise of warrants (in shares)         200,000            
Common stock issued upon exercise of warrants 653         653          
Common stock issued in extinguishment of senior notes (in shares)         36,903            
Common stock issued in extinguishment of senior notes 1,011         1,011          
RSU equity awards reclassified to liability 0                    
Share based payments 18,774         18,774          
Share based payments in equity of subsidiary 140         140          
Vesting of shares in equity of subsidiary 0         (143)         143
Dividends on common stock, net of forfeitures (17,377)           (17,377)        
Dividends on preferred stock   $ (4,872) $ (3,188)         $ (4,872) $ (3,188)    
Net income (loss) (774,939)           (764,274)       (10,665)
Distributions to noncontrolling interests (9,119)                   (9,119)
Common stock issuance in equity of subsidiary and contributions from noncontrolling interests 3,947                   3,947
Acquisition of noncontrolling interests 4,650                   4,650
Disposition of noncontrolling interests (25,246)                   (25,246)
Other comprehensive income (loss) (6,798)                 (6,798)  
Ending balance (in shares) at Dec. 31, 2024       4,563 30,499,931            
Ending balance at Dec. 31, 2024 (456,016)     $ 0 $ 3 589,387 (1,070,996)     (6,569) 32,159
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Common stock issued, net of offering costs (in shares)         100,000            
Common stock issued, net of offering costs 295         295          
RSU equity awards reclassified to liability (2,138)         (2,138)          
Common stock forfeited (in shares)         (2,865)            
Warrants issued 1,848         1,848          
Share based payments 8,678         8,678          
Share based payments in equity of subsidiary 3,561         23         3,538
Vesting of shares in equity of subsidiary (71)         (71)         0
Dividend forfeitures on unvested equity awards 295           295        
Net income (loss) 310,285           307,415       2,870
Distributions to noncontrolling interests (4,283)                   (4,283)
Common stock issuance in equity of subsidiary and contributions from noncontrolling interests 1,575                   1,575
Disposition from sale and deconsolidation of businesses 2,918                   2,918
Initial consolidation of VIE 12,494                   12,494
Other comprehensive income (loss) 297                 297  
Ending balance (in shares) at Dec. 31, 2025       4,563 30,597,066            
Ending balance at Dec. 31, 2025 $ (120,262)     $ 0 $ 3 $ 598,022 $ (763,286)     $ (6,272) $ 51,271